Skip to main content
. 2020 Mar 2;39(17):3541–3554. doi: 10.1038/s41388-020-1237-0

Fig. 6. Clinical significance of XCL1 overexpression in MCT-SCC.

Fig. 6

a Heatmaps demonstrate both clinical information and immunohistochemical findings in 24 MCT-SCC/ASCs. b Bar graphs show tumor-infiltrating CD8-positive T cells and PD-L1 expression in MCT-SCC/ASCs between XCL1-positive and XCL1-neagtive patients. c Our hypothesis of PD-L1/PD1-mediated cytotoxic T-lymphocyte dysfunction following XCL1 production by MCT-SCC is shown.